Loading articles...

First AstraZeneca-linked death confirmed in Alberta

Vials of the AstraZeneca COVID-19 vaccine sit in a fridge at the local vaccine center in Ebersberg near Munich, Germany. March, 22, 2021. THE ASSOCIATED PRESS/Matthias Schrader/File
Summary

A woman in her 50s died due to vaccine related complications surrounding the Oxford-AstraZeneca vaccine.

Dr. Hinshaw notes the risks of dying or suffering other severe outcomes from COVID-19 remain a far greater risk.

It's the first death tied to more than 253,000 doses administered in the province.

ALBERTA – (660 NEWS) – Alberta’s chief medical officer of health confirmed the death of a patient linked to the Oxford-AstraZeneca vaccine, late Tuesday night.

In a statement, Dr. Deena Hinshaw said the woman in her 50s died from immune thrombotic thrombocytopenia (VITT).

According to the website for the National Organization for Rare Disorders (NORD), the illness is an autoimmune bleeding disorder characterized by low levels of blood cells called platelets.

Dr. Hinshaw notes the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine. It’s the first death tied to more than 253,000 doses administered in the province.

A 54-year-old woman in Quebec also died in a VITT case after getting the Oxford-AstraZeneca shot last month.

 

RELATED: